M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes

Objective Doxorubicin (DOX) is an anthracycline antibiotic which is widely used for the treatment of various cancers, while the dose-related cardiotoxicity limits its potential therapeutic application. The underlying mechanism of DOX induced cardiotoxicity is complex and remains elusive. Our previous studies have shown that M2b macrophage plays an important role in reducing inflammation due to ischemic reperfusion injury in the myocardium. The purpose of this study was to investigate the potential protective role of M2b macrophages in DOX induced cardiotoxicity. Methods In vivo, we conducted DOX induced cardiac injury in C57BL/6 mice and treated them with M2b macrophages. Then, the mice were examined by echocardiography. The heart specimens were harvested for histological examination, transmission electron microscope analysis, and autophagy molecules evaluation. In vitro, HL-1 cardiac cell lines treated with DOX were cocultured with or without M2b macrophages. Then, Autophagy related genes and protein expression were assessed by real-time quantitative PCR and western blot; cell proliferation was assessed by cell counting kit-8. Results We found that M2b macrophages can improve cardiac function and alleviate cardiac injury in DOX induced cardiac injury mice. M2b macrophages can enhance cardiac autophagy levels both in vivo and in vitro in DOX induced cardiac injury model. In addition, this protective effect can be blocked by an autophagy inhibitor. Conclusion Our study shows that M2b macrophages can help attenuate the DOX induced cardiotoxicity by regulating the autophagy level of cardiomyocytes.

[1]  C. Dass,et al.  Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. , 2022, The Journal of pharmacy and pharmacology.

[2]  Yating Qin,et al.  Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis , 2022, Cardiovascular therapeutics.

[3]  J. Imig,et al.  Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes , 2021, Cells.

[4]  Jun Gu,et al.  Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells , 2021, Redox biology.

[5]  L. Bharath,et al.  Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases , 2021, Cells.

[6]  Mi-Sung Kim,et al.  All cells are created equal in the sight of autophagy: selective autophagy maintains homeostasis in senescent cells , 2021, Autophagy.

[7]  Zhongkai Wu,et al.  Characterization of mRNA Profiles of Exosomes from Diverse Forms of M2 Macrophages , 2020, BioMed research international.

[8]  S. Priori,et al.  A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart , 2020, Cell.

[9]  Hangyuan Guo,et al.  Fucoidan from Fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Xuan Sun,et al.  Self-Maintenance of Cardiac Resident Reparative Macrophages Attenuates Doxorubicin-Induced Cardiomyopathy Through the SR-A1-c-Myc Axis , 2020, Circulation research.

[11]  Zhongkai Wu,et al.  Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway , 2020, PeerJ.

[12]  Dinender K. Singla,et al.  Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy , 2019, Cells.

[13]  J. Rossignol,et al.  Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes neuroprotection in a rat model of TBI , 2019, Journal of cellular and molecular medicine.

[14]  Ray-Jade Chen,et al.  IGF-IIRα is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy. , 2019, American journal of physiology. Cell physiology.

[15]  Osamu Yamaguchi,et al.  Autophagy in the Heart. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[16]  M. Ferrer,et al.  Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy , 2018, Breast Cancer Research and Treatment.

[17]  X. Yang,et al.  M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: A predominant role of inhibiting apoptosis via A20. , 2017, International journal of cardiology.

[18]  Andrej J. Savol,et al.  Macrophages Facilitate Electrical Conduction in the Heart , 2017, Cell.

[19]  E. Baehrecke,et al.  Cleaning House: Selective Autophagy of Organelles. , 2017, Developmental cell.

[20]  E. Kardami,et al.  Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity , 2017, Oncotarget.

[21]  Katherine E Henson,et al.  Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age , 2016, Circulation.

[22]  Herman I. May,et al.  Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification , 2016, Circulation.

[23]  Wei Hu,et al.  Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity. , 2016, International immunopharmacology.

[24]  L. Rochette,et al.  Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. , 2015, Trends in pharmacological sciences.

[25]  Yong Cheng,et al.  Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. , 2014, Journal of molecular and cellular cardiology.

[26]  X. Cen,et al.  Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. , 2014, Biochemical pharmacology.

[27]  Jun Ren,et al.  Macrophage Migration Inhibitory Factor Deficiency Augments Doxorubicin‐Induced Cardiomyopathy , 2013, Journal of the American Heart Association.

[28]  M. Kawasaki,et al.  Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. , 2012, Cardiovascular research.

[29]  E. Yeh,et al.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity , 2012, Nature Medicine.

[30]  H. Crijns,et al.  Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. , 2012, Journal of molecular and cellular cardiology.

[31]  Satoru Kobayashi,et al.  Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death* , 2009, The Journal of Biological Chemistry.

[32]  Jianyun Yan,et al.  Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. , 2009, International journal of cardiology.

[33]  U. Brunk,et al.  Autophagy in cardiac myocyte homeostasis, aging, and pathology. , 2005, Cardiovascular research.

[34]  S. Swain,et al.  Congestive heart failure in patients treated with doxorubicin , 2003, Cancer.

[35]  Hongwei Du,et al.  Decreased expression of adenosine receptor 2B confers cardiac protection against ischemia via restoring autophagic flux. , 2020, American journal of translational research.

[36]  Ray-Jade Chen,et al.  Insulin-like growth factor II receptor- is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy , 2019 .